Who
Jeffrey David Jacobson
Chief Growth Officer
Company insider
Files Form 4 as: Chief Growth Officer, Cronos Group.
In numbers
- Trades disclosed
- 68
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $61K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Aug 2020
- Last trade
- 15 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —59,191 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $56K22,552 at $2.50 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —59,191 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —59,191 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —59,191 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $56K22,552 at $2.50 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —65,179 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $64K24,926 at $2.56 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —65,179 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —65,179 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —65,179 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $64K24,926 at $2.56 | filing |
| 9 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —144,561 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —144,561 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —60,536 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $66K25,605 at $2.57 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —60,536 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —60,536 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —60,536 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $66K25,605 at $2.57 | filing |
News
Head-To-Head Survey: Cronos Group (NASDAQ:CRON) versus Indivior (NASDAQ:INDV)CRON · dailypolitical.com · 22 Oct 2026Comparing Cronos Group (NASDAQ:CRON) and Eton Pharmaceuticals (NASDAQ:ETON)CRON · dailypolitical.com · 13 Oct 2026Reviewing Cronos Group (NASDAQ:CRON) and Urogen Pharma (NASDAQ:URGN)CRON · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name Jeffrey David Jacobson; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.